Dihydropyrimidine dehydrogenase pharmacogenetics in the Taiwanese population

Author： Hsiao Hui-Hua   Yang Ming-Yu   Chang Jan-Gowth   Liu Yi-Chang   Liu Ta-Chih   Chang Chao-Sung   Chen Tyen-Po   Lin Sheng-Fung  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.53, Iss.5, 2004-05, pp. : 445-451

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The significance of dihydropyrimidine dehydrogenase (DPD) activity in bladder cancer

By Mizutani Y.   Wada H.   Fukushima M.   Yoshida O.   Ukimura O.   Kawauchi A.   Miki T.  

European Journal of Cancer, Vol. 37, Iss. 5, 2001-03 ,pp. : 569-575

Elsevier

Access to resources Recommend Favorite

Significance of dihydropyrimidine dehydrogenase activity in renal cell carcinoma

By Mizutani Y.   Wada H.   Yoshida O.   Fukushima M.   Nakanishi H.   Nakao M.   Miki T.  

European Journal of Cancer, Vol. 39, Iss. 4, 2003-03 ,pp. : 541-547

Elsevier

Access to resources Recommend Favorite

Screening for Dihydropyrimidine Dehydrogenase Deficiency: To Do or Not To Do, That's The Question

By van Kuilenburg André  

Cancer Investigation, Vol. 24, Iss. 2, 2006-05 ,pp. : 215-217

Informa Healthcare

Access to resources Recommend Favorite

Thymidylate synthetase and dihydropyrimidine dehydrogenase mRNA levels in esophageal cancer

By Kimura Masahiro   Kuwabara Yoshiyuki   Mitsui Akira   Ishiguro Hideyuki   Sugito Nobuyoshi   Tanaka Tatsuya   Shiozaki Midori   Naganawa Yasuhiro   Takeyama Hiromitsu  

Oncology Letters, Vol. 2, Iss. 2, 2011-03 ,pp. : 297-301

Spandidos Publications

Access to resources Recommend Favorite

Can dihydropyrimidine dehydrogenase impact 5-fluorouracil-based treatment? - results of a phase I/II trial

By Milano G.   McLeod H.L.  

European Journal of Cancer, Vol. 36, Iss. 1, 2000-01 ,pp. : 37-42

Elsevier

Access to resources Recommend Favorite